Cancer Immunology and Oncolytic Virology: Technologies and Global Markets Report 2017-2021 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cancer Immunology and Oncolytic Virology: Technologies and Global Markets" report to their offering.

The scope of this report covers current cancer immunotherapy markets for most common cancers. The market segments included in this report are therapeutic monoclonal antibodies (with special focus on checkpoint inhibitors), synthetic interleukins, interferons, and colony-stimulating factors; small kinase inhibitors of cancer-related targets; protective and therapeutic cancer vaccines; and adoptive cell therapies.

This report also covers treatments that are in development for late-stage and early-stage oncolytic viruses. Detailed epidemiological information, discussion of incidence and mortality trends, overview of regulatory landscapes, and analysis of market shares for leading products and companies are also included in this report.

Report Includes

  • An overview of the global markets for cancer immunotherapies and oncolytic virology.
  • Analyses of global market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Analyses of factors influencing market demand, such as clinical guidelines, demographic changes, and market saturation.
  • Information covering the latest trends, market structure, market size, key drug segments, and trends in technology.
  • Coverage of colony stimulating factors (CSFs), interferon alfa and gamma products, interleukin products and therapeutic monoclonal antibodies, including antibody conjugates, cancer vaccines, and other cancer treatment immunology products.
  • Technological discussions, including the current state, newly issued patents, and pending applications.
  • Profiles of leading companies in the industry.

Key Topics Covered:

1: Introduction

2: Summary and Highlights

3: Overview

4: Overview of Cancer Immunotherapy

5: Oncolytic Virology

6: Major Markets

7: Company Profiles

  • Abbvie Inc.
  • Dendreon
  • Dnatrix
  • Eisai
  • Eli Lilly
  • Janssen Pharmaceuticals
  • Kadmon Pharmaceuticals Corp.
  • Kite Pharmaceuticals Inc.
  • Kyowa Hakko Kirin Co. Ltd.
  • Ligand Pharmaceuticals Inc.
  • Lion Biotechnologies
  • Lokon Pharmaceuticals AB
  • Medimmune
  • Merck & Co.
  • Merck Kgaa
  • Northwest Biotherapeutics
  • Novartis Pharma Services AG
  • Oncolys Biopharma Inc.
  • Oncolytics Biotech Inc.
  • Oncomed Pharmaceuticals Inc.
  • Oncos Therapeutics Ltd.
  • Ono Pharmaceutical Co.
  • Otsuka Pharmaceutical Co., Ltd.
  • Sillajen Biotherapeutics Inc.
  • Spectrum Pharmaceuticals
  • Takara Bio Inc.
  • Transgene
  • VCN Biosciences
  • Ventirx
  • Verastem Inc.
  • Viralytics Ltd.
  • Virttu Biologics Ltd
  • Vyriad
  • Western Oncolytics Ltd.

For more information about this report visit http://www.researchandmarkets.com/research/hzld86/cancer_immunology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology